Evaluation of statistical power function for various diclofenac bioequivalence trials with different subject numbers
- 1 June 2009
- journal article
- research article
- Published by Springer Nature in European Journal of Drug Metabolism and Pharmacokinetics
- Vol. 34 (2) , 85-91
Abstract
This study presents application of statistical power function for thet-test and ANOVAF-test on the evaluation of diclofenac bioequivalence in trials with the wide variations in sample sizes (N=12, 18 and 24). The power function, together with appropriate equations tables and figures, is used to calculate the power of the ANOVA for crossover design, the number of subjects for a given value of power and the minimum detectable difference in treatment means for different pharmacokinetic parameters of the formulations. The power of the trial with a small, sample size (N=12) to detect 20% differences between diclofenac formulations is shown to be more than 0.9 and almost the same as the power of the trial with a large sample size (N=24). In all trials for all pharmacokinetic parameters the power to detect 20% difference is shown to be more than 0.8. For the power of 0.8, the needed subject number to detect 20% difference in treatment means is the same or smaller than used and the minimum detectable difference is smaller than 20% in all our trials. This investigation shows that bioequivalence studies with small number of subjects (N=12) may be quite adequate for valid conclusions.Keywords
This publication has 19 references indexed in Scilit:
- Pharmacokinetics of carbamazepine derived from a new tablet formulationEuropean Journal of Drug Metabolism and Pharmacokinetics, 1995
- Statistical aspects of bioequivalence—a reviewXenobiotica, 1992
- A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailabilityJournal of Pharmacokinetics and Biopharmaceutics, 1987
- Bioavailability of imipramine tablets relative to a stable isotope-labeled internal standard: Increasing the power of bioavailability testsJournal of Pharmacokinetics and Biopharmaceutics, 1979
- CHARTS OF THE POWER FUNCTION FOR ANALYSIS OF VARIANCE TESTS, DERIVED FROM THE NON-CENTRAL F-DISTRIBUTIONBiometrika, 1951
- POWER OF THE MODIFIED t-TEST (u-TEST) BASED ON RANGEBiometrika, 1950
- ALTERNATIVE SYSTEMS IN THE ANALYSIS OF VARIANCEBiometrika, 1948
- Inverse Tables of Probabilities of Errors of the Second KindThe Annals of Mathematical Statistics, 1944
- APPLICATIONS OF THE NON-CENTRAL t-DISTRIBUTIONBiometrika, 1940
- ON AN IMPORTANT CLASS OF STATISTICAL HYPOTHESESBiometrika, 1935